ABUS - Financial Reports List - Arbutus Biopharma Corporation - IntrinsicAlpha

Arbutus Biopharma Corporation ABUS

Healthcare - Biotechnology - NASDAQ - US

$ 3.21

1.9 %

$ 608 M

Market Cap

-8.45

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-26.62%	35.11%	32.10%
Annual Report	FY	10-K	2024-12-31	-65.98%	4.02%	2.28%
Quarterly Report	Q3	8-K	2024-09-30	-71.25%	1.92%	0.55%
Quarterly Report	Q2	8-K	2024-06-30	-62.89%	-15.81%	-16.25%
Quarterly Report	Q1	8-K	2024-03-31	-77.09%	-15.60%	-10.16%
Quarterly Report	Q4	8-K	2023-12-31	-65.65%	15.71%	9.05%
Annual Report	FY	10-K	2023-12-31	-53.51%	-4.89%	-19.32%
Quarterly Report	Q3	8-K	2023-09-30	-21.74%	-16.05%	-21.04%
Quarterly Report	Q2	8-K	2023-06-30	-67.34%	-19.75%	-30.31%
Quarterly Report	Q1	8-K	2023-03-31	-46.85%	1.92%	-58.68%

1